An illustrated text logo for the company Grafa Pty Ltd
NewsSignalsMarketsAbout
    • Hub
    • News
    • Signals
    • Market
    • Search

    When you have the data, you don't need luck.

    Spot the trend before it moves. See what's hot before everyone else.

    Grafa is a high-speed market data engine for discovering breakout stocks, crypto and high-yield opportunities.

    Latest Signals
    Trending Stocks
    Trending Crypto
    News Headlines
    Create Watchlist

    Discover 20,000+ opportunities

    • Personalized, Intelligent Investing

      Instantly tailor your hub to your stocks, crypto and forex.

    • AI-Powered Screening & Insights

      Real-time scans across ASX, NASDAQ, NYSE and more.

    • Global Coverage Comprehensive Data

      Actionable insights and instant alerts.

    Continue with Email

    By continuing, you agree to Grafa's Terms of Service and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Discover opportunities before anyone else

    • Find it fast

      Effortlessly track your favorite assets and receive instant price alerts.

    • Find it first

      Spot new market trends before anyone else, powered by AI.

    • Dig Deeper

      Access data on 20,000+ stocks, crypto, and currencies worldwide.

    • Make it count

      Invest with confidence—clear data, actionable insights, and expert content.

    Discover opportunities before anyone else

    Find it fast

    Effortlessly track your favorite assets and receive instant price alerts.

    See demo

    Find it first

    Spot new market trends before anyone else, powered by AI.

    See demo

    Dig Deeper

    Access data on 20,000+ stocks, crypto, and currencies worldwide.

    See demo

    Make it count

    Invest with confidence—clear data, actionable insights, and expert content.

    See demo

    Grafa app screenshot showing AI market screener dashboard
    Get Grafa for free
    Continue with Email

    By continuing, you agree to Grafa's Terms of Service and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Trending News

    Read SpaceX IPO a Datapoint to Higher Market Prices, Says Julian Emanuel
    SpaceX IPO a Datapoint to Higher Market Prices, Says Julian Emanuel
    Bloomberg
    9 hours ago

    SpaceX IPO a Datapoint to Higher Market Prices, Says Julian Emanuel

    Read Driven Brands rebounds in first quarter led by Take 5 expansion
    Driven Brands rebounds in first quarter led by Take 5 expansion
    Grafa
    8 hours ago

    Driven Brands rebounds in first quarter led by Take 5 expansion

    Read Vera Bradley rebounds on first revenue growth since 2022
    Vera Bradley rebounds on first revenue growth since 2022
    Grafa
    8 hours ago

    Vera Bradley rebounds on first revenue growth since 2022

    Read Lovesac post Q1 loss on flat sales, maintains full-year outlook
    Lovesac post Q1 loss on flat sales, maintains full-year outlook
    Grafa
    9 hours ago

    Lovesac post Q1 loss on flat sales, maintains full-year outlook

    Read Aurora Cannabis posts record full-year results on International Medical growth
    Aurora Cannabis posts record full-year results on International Medical growth
    Grafa
    16 hours ago

    Aurora Cannabis posts record full-year results on International Medical growth

    Read Dana to merge with Eaton’s mobility arm in $5.1 billion deal
    Dana to merge with Eaton’s mobility arm in $5.1 billion deal
    Grafa
    9 hours ago

    Dana to merge with Eaton’s mobility arm in $5.1 billion deal

    Read Hooker Furnishings swings to Q1 profit despite soft demand
    Hooker Furnishings swings to Q1 profit despite soft demand
    Grafa
    10 hours ago

    Hooker Furnishings swings to Q1 profit despite soft demand

    Read Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial
    Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial
    Grafa
    16 hours ago

    Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial

    Read Takeda zasocitinib beats deucravacitinib in Phase 3 psoriasis trial
    Takeda zasocitinib beats deucravacitinib in Phase 3 psoriasis trial
    Grafa
    9 hours ago

    Takeda zasocitinib beats deucravacitinib in Phase 3 psoriasis trial

    Read Nurix Therapeutics shares drop despite positive leukemia drug data
    Nurix Therapeutics shares drop despite positive leukemia drug data
    Grafa
    8 hours ago

    Nurix Therapeutics shares drop despite positive leukemia drug data

    Got questions?

    As seen on

    • The West Australian
    • Financial Review
    • The Sydney Morning Herald
    • Tiger Brokers

    Empowering Financial Confidence

    Grafa's mission is to democratize financial knowledge for all investors, from first-timers to seasoned pros.

    Legal & info

    • T&Cs
    • Privacy Policy
    • Site Map
    • About

    Get in touch

    • Contact
    • Support
    • Editorial
    • Advertising

    Connect with us